Lisa Nonnenmacher
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Oncogene aberrations drive medulloblastoma progression, not initiation.
Journal: Nature
Published: January 03, 2024
Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells.
Journal: International journal of oncology
Published: March 08, 2018
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach.
Journal: Scientific reports
Published: November 24, 2017
The effects of PI3K-mediated signalling on glioblastoma cell behaviour.
Journal: Oncogenesis
Published: July 17, 2017
Abstracts of the 52nd Workshop for Pediatric Research : Frankfurt, Germany. 27-28 October 2016.
Journal: Molecular and cellular pediatrics
Published: May 19, 2017
Cell Death Induction in Cancer Therapy - Past, Present, and Future.
Journal: Critical reviews in oncogenesis
Published: December 06, 2016
Simultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in Vitro.
Journal: Neurochemical research
Published: June 17, 2016
Immune phenotypes predict survival in patients with glioblastoma multiforme.
Journal: Journal of hematology & oncology
Published: February 05, 2016
A paired comparison between glioblastoma "stem cells" and differentiated cells.
Journal: International journal of cancer
Published: June 08, 2015
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
Journal: PloS one
Published: March 13, 2015
RIST: a potent new combination therapy for glioblastoma.
Journal: International journal of cancer
Published: March 23, 2014
Last Updated: 09/26/2026